Rothschild Investment LLC’s Mirum Pharmaceuticals MIRM Stock Holding History

Rothschild Investment LLC’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.01K	Buy	77 +12	+18%	+$1.21K	﹤0.01%	1940
2026 Q1	$6K	Hold	65	–	–	﹤0.01%	1961
2025 Q4	$5.13K	Hold	65	–	–	﹤0.01%	1865
2025 Q3	$4.76K	Sell	65 -10	-13%	-$636	﹤0.01%	1732
2025 Q2	$3.82K	Hold	75	–	–	﹤0.01%	1644
2025 Q1	$3.38K	Buy	75 +30	+67%	+$1.41K	﹤0.01%	1622
2024 Q4	$1.86K	Hold	45	–	–	﹤0.01%	1845
2024 Q3	$1.75K	Buy	45 +30	+200%	+$1.2K	﹤0.01%	1802
2024 Q2	$513	Buy	15 +10	+200%	+$262	﹤0.01%	1999
2024 Q1	$126	Buy	+5	New	+$137	﹤0.01%	2060
2022 Q1	–	Sell	-15,500	Closed	-$247K	–	530
2021 Q4	$247K	Buy	+15,500	New	+$241K	0.02%	444
2021 Q3	–	Sell	-11,600	Closed	-$201K	–	503
2021 Q2	$201K	Buy	+11,600	New	+$208K	0.02%	462

Other funds holding MIRM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Rothschild Investment LLC's MIRM Position: Q2 2026 in Review

Rothschild Investment LLC increased its Mirum Pharmaceuticals (MIRM) stake by 18% in Q2 2026, buying an estimated $1.21K and bringing the position to 77 shares worth $9.01K. The position accounts for ﹤0.01% of the portfolio, ranked #1940.

Rothschild Investment LLC first reported a position in MIRM in Q2 2021 and has held it in 12 quarters since. The position peaked at $247K in Q4 2021. 114 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Rothschild Investment LLC held 77 shares of Mirum Pharmaceuticals worth $9.01K as of Q2 2026.
Rothschild Investment LLC bought 12 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.21K.
Mirum Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1940 holding.
Rothschild Investment LLC first reported a position in Mirum Pharmaceuticals in Q2 2021 and has held it in 12 quarters since.
Rothschild Investment LLC's Mirum Pharmaceuticals position peaked at $247K in Q4 2021.
114 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.